Related Experiment Videos
A selection of candidate compounds for in vitro teratogenesis test validation
Teratogenesis, Carcinogenesis, and Mutagenesis
|January 1, 1983
Summary
This study lists 47 agents with defined in vivo teratogenicity to aid in validating in vitro teratogenesis tests. This curated list supports the development of more effective chemical safety testing programs.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- In vitro teratogenesis testing requires reliable agents for validation.
- A consensus workshop recommended establishing a list of teratogenic agents.
- Defining such agents is crucial for test development and regulatory acceptance.
Purpose of the Study:
- To establish a definitive list of agents with known in vivo teratogenicity.
- To provide a foundation for validating in vitro teratogenesis assays.
- To facilitate the development of more predictive developmental toxicity testing strategies.
Main Methods:
- A panel reviewed and selected agents based on existing literature.
- Agents were chosen for their well-documented in vivo teratogenic effects.
- Data on biological, toxicological, and teratological characteristics were compiled.
Main Results:
- A list of 47 compounds and conditions with defined in vivo teratogenicity was established.
- Literature-based evidence of in vivo effects formed the primary selection criterion.
- Detailed summaries and references for representative studies are provided.
Conclusions:
- The compiled list serves as a critical resource for in vitro teratogenesis test validation.
- This resource will aid in identifying and developing effective in vitro testing systems.
- The list supports the advancement of more efficient and reliable developmental toxicity testing programs.